Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley R Riddell

Showing results (51-60 of 177) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2009
Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemiaTetsuya Nishida, Michael Hudecek, Ana Kostic, et al.
The Journal of Infectious Diseases|August 27, 2002
Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell responseHelen P Mutimer, Yoshiki Akatsuka, Thomas Manley, et al.
British Journal of Haematology|April 9, 2005
A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantationSeitaro Terakura, Makoto Murata, Tetsuya Nishida, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2005
Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cellsVeronika Groh, Yongqing Q Li, Daniel Cioca, et al.
Virology|March 12, 2002
HIV-1 Vpr does not inhibit CTL-mediated apoptosis of HIV-1 infected cellsDeborah A Lewinsohn, Rebecca Lines, David M Lewinsohn, et al.
Transplantation|December 25, 2002
Targeted cloning of cytotoxic T cells specific for minor histocompatibility antigens restricted by HLA class I molecules of interestYoshiki Akatsuka, Eisei Kondo, Hirohumi Taji, et al.
The Journal of Experimental Medicine|December 8, 2004
CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patientsAdrian F Ochsenbein, Stanley R Riddell, Michele Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2013
Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cellsMichael Hudecek, Maria-Teresa Lupo-Stanghellini, Paula L Kosasih, et al.
Blood|October 14, 2009
Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unitJonathan A Gutman, Cameron J Turtle, Thomas J Manley, et al.
Human Gene Therapy|July 10, 2004
Enhanced transgene expression in quiescent and activated human CD8+ T cellsLaurence J N Cooper, Max S Topp, Cris Pinzon, et al.
Pageof 18

Showing results (51-60 of 177) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2009
Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemiaTetsuya Nishida, Michael Hudecek, Ana Kostic, et al.
The Journal of Infectious Diseases|August 27, 2002
Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell responseHelen P Mutimer, Yoshiki Akatsuka, Thomas Manley, et al.
British Journal of Haematology|April 9, 2005
A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantationSeitaro Terakura, Makoto Murata, Tetsuya Nishida, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2005
Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cellsVeronika Groh, Yongqing Q Li, Daniel Cioca, et al.
Virology|March 12, 2002
HIV-1 Vpr does not inhibit CTL-mediated apoptosis of HIV-1 infected cellsDeborah A Lewinsohn, Rebecca Lines, David M Lewinsohn, et al.
Transplantation|December 25, 2002
Targeted cloning of cytotoxic T cells specific for minor histocompatibility antigens restricted by HLA class I molecules of interestYoshiki Akatsuka, Eisei Kondo, Hirohumi Taji, et al.
The Journal of Experimental Medicine|December 8, 2004
CD27 expression promotes long-term survival of functional effector-memory CD8+ cytotoxic T lymphocytes in HIV-infected patientsAdrian F Ochsenbein, Stanley R Riddell, Michele Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2013
Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cellsMichael Hudecek, Maria-Teresa Lupo-Stanghellini, Paula L Kosasih, et al.
Blood|October 14, 2009
Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unitJonathan A Gutman, Cameron J Turtle, Thomas J Manley, et al.
Human Gene Therapy|July 10, 2004
Enhanced transgene expression in quiescent and activated human CD8+ T cellsLaurence J N Cooper, Max S Topp, Cris Pinzon, et al.
Pageof 18